Cancer BiologybioRxivPreprint
HO-3867 mediated modulation of Extracellular vesicles and Tumor microenvironment: A novel immunotherapeutic strategy for ovarian cancer
Ganesh Yadagiri, Lakshmi Narasimhan Chakrapani, Shyam Sundaram…·Kalpana Deepa Priya Dorayappan
This study shows that HO-3867 and bevacizumab together reduce ascites, limit tumor spread, and enhance anti-tumor immunity in ovarian cancer models by modulating extracellular vesicles and immune cells.
DOI 10.1101/2025.05.16.653814